The c-FLIPL Cleavage Product p43FLIP Promotes Activation of Extracellular Signal-regulated Kinase (ERK), Nuclear Factor κB (NF-κB), and Caspase-8 and T Cell Survival*

  1. Ralph C. Budd,§
  1. From the Vermont Center for Immunology and Infectious Diseases and
  2. Departments of §Medicine and
  3. Pathology, The University of Vermont College of Medicine, Burlington, Vermont 05405,
  4. the Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, BioCity, FIN-20521 Turku, Finland,
  5. the **Department of Biological Sciences, Åbo Akademi University, BioCity, FIN-20520 Turku, Finland,
  6. the ‡‡Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710, and
  7. the §§Ontario Cancer Institute, Department of Medical Biophysics, University of Toronto, Toronto M5G 2C1, Canada
  1. 1 To whom correspondence should be addressed: Immunobiology Program, The University of Vermont College of Medicine, Given Medical Bldg., C-344, 89 Beaumont Ave., Burlington, VT 05405-0068. Tel.: 802-656-2289; Fax: 802-656-3854; E-mail: akoenig{at}uvm.edu.

Background: c-FLIPL is a regulator of caspase-8 activity in T lymphocytes.

Results: Caspase-8 activity is lost upon deletion of c-FLIPL. p43FLIP rescues caspase-8 activity through Raf1, TRAF2, and RIPK1 association, augmenting ERK and NF-κB pathways.

Conclusion: The FLIPL cleavage product p43FLIP promotes activation of pathways involved with T cell growth.

Significance: This study provides new insight into the regulation of caspase-8 activity by c-FLIP.

Abstract

Caspase-8 is now appreciated to govern both apoptosis following death receptor ligation and cell survival and growth via inhibition of the Ripoptosome. Cells must therefore carefully regulate the high level of caspase-8 activity during apoptosis versus the modest levels observed during cell growth. The caspase-8 paralogue c-FLIP is a good candidate for a molecular rheostat of caspase-8 activity. c-FLIP can inhibit death receptor-mediated apoptosis by competing with caspase-8 for recruitment to FADD. However, full-length c-FLIPL can also heterodimerize with caspase-8 independent of death receptor ligation and activate caspase-8 via an activation loop in the C terminus of c-FLIPL. This triggers cleavage of c-FLIPL at Asp-376 by caspase-8 to produce p43FLIP. The continued function of p43FLIP has, however, not been determined. We demonstrate that acute deletion of endogenous c-FLIP in murine effector T cells results in loss of caspase-8 activity and cell death. The lethality and caspase-8 activity can both be rescued by the transgenic expression of p43FLIP. Furthermore, p43FLIP associates with Raf1, TRAF2, and RIPK1, which augments ERK and NF-κB activation, IL-2 production, and T cell proliferation. Thus, not only is c-FLIP the initiator of caspase-8 activity during T cell activation, it is also an initial caspase-8 substrate, with cleaved p43FLIP serving to both stabilize caspase-8 activity and promote activation of pathways involved with T cell growth.

Footnotes

  • * This work was supported, in whole or in part, by National Institutes of Health Grants GM103496, AI36333, and AI45666.

  • Received July 30, 2013.
  • Revision received November 6, 2013.
Table of Contents

This Article

  1. The Journal of Biological Chemistry 289, 1183-1191.
  1. All Versions of this Article:
    1. M113.506428v1
    2. 289/2/1183 (most recent)

Classifications

Article Usage Stats

Submit your work to JBC.

You'll be in good company.